Results 91 to 100 of about 4,596 (150)

非小细胞肺癌内血管内皮生长因子的RT-PCR表达测定

Zhongguo shiyan zhenduanxue, 2007
目的探讨非小细胞肺癌（NSCLC）组织中VEGF mRNA的表达特点。方法应用RT-PCR方法,检测56例非小细胞肺癌组织和10例良性肺肿瘤组织及正常肺组织的VEGF mRNA的表达情况,并分析其与病理特征之间的关系。结果VEGF mRNA在正常肺组织及良性肺肿瘤组织几乎无阳性表达,而在非小细胞肺癌中84.56%有阳性表达;VEGFmRNA在不同组织类型肿瘤中的表达无统计学差异;在临床分期III期的肿瘤中VEGFmRNA的表达量与临床分期II、I期的肿瘤相比明显过表达,两两组间对比存在统计学差异 ...
李冬, 杨海山
doaj  

p53基因Msp I位点多态性与NSCLC易感性及辐射敏感性关系的研究

Zhongguo shiyan zhenduanxue, 2006
目的研究中国北方人对非小细胞肺癌（NSCLC）的易感性及放疗敏感性与p53基因Msp I单核苷酸多态性（SNP）的关系。方法采用病例对照方法,通过合成序列特异性引物（PCR-RFLP）方法检测50例NSCLC患者及56例健康对照者的p53基因Msp I单核苷酸多态性位点的基因型。同时,观察不同基因型患者的放射治疗疗效,检测与辐射敏感性相关的基因型。结果NSCLC组的A1/A2杂和基因型频率明显高于对照组（χ2=4.38 ...
马忠余, 邵国光, 刘琳琳, 李健强, 郑永晨   +4 more
doaj  

[Expression, Prognostic and Functional Analysis of SRSF Family Proteins 
in Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Tu S, Chen Y, Zhang Y, Chen Q, Fan Y, Wang Y, Zhang Y, Li S, Chen J, Pan H, Zhou X, Li X.   +11 more
europepmc   +1 more source

[Influence and Mechanism of Immunophenotyping on the Efficacy 
of Neoadjuvant Therapy in Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Wu L, Yang L, Zhao M, Sun J, Cao F, Chen Q, Sun X, Xing L.   +7 more
europepmc   +1 more source

[<i>Shengmai San</i> improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liang Z, Pan F, Deng L, Mai Z, Ma Y, Shi C, Fu W.   +6 more
europepmc   +1 more source

系统性免疫炎症指数对晚期非小细胞肺癌患者预后的预测价值

Zhongguo shiyan zhenduanxue
目的 探讨系统性免疫炎症指数(SII)对晚期非小细胞肺癌患者预后的预测价值。方法 自2019年1月至2022年6月，回顾性收集新疆医科大学附属肿瘤医院收治的晚期非小细胞肺癌患者143例，对患者随访1年，观察患者是否发生肿瘤特异性死亡，将患者分为死亡组(n=67)和对照组(n=76),比较两组患者系统性免疫炎症指数和其他临床特征差异，分析晚期非小细胞肺癌死亡的危险因素，同时分析系统性免疫炎症指数对肿瘤特异性死亡的预测价值。结果 与对照组比较，死亡组原发肿瘤最大径增大(5.66±2.53 cm vs.4 ...
杨燕, 顾国民
doaj  

[Research Progress on Interleukin-6 in Screening and Prognosis of Patients 
with Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Xu D, Qiao C, Zhang X, Kong Q, Ji X.
europepmc   +1 more source

[Clinical Significance of Extranodal Extension in Non-small Cell Lung Cancer: 
Current Status and Future Prospects]. [PDF]

Zhongguo Fei Ai Za Zhi
Liang H, Meng Y, Wang Q, Li C, Yang H, Xiang X.   +5 more
europepmc   +1 more source

A Case Report of Erlotinib as First-line Therapy in Extensive Metastatic Patient with Advanced Non-small Cell Lung Cancer [PDF]

, 2009
Wanfeng GUO, Xiaoqing LIU
core  

[Chinese Expert Consensus on Clinical Management of Oncogene Addicted 
Non-small Cell Lung Cancer with Leptomeningeal Metastasis (2026 Edition)]. [PDF]

Zhongguo Fei Ai Za Zhi
Lung Cancer Medical Education Committee of Chinese Medical Education Association, Metastasis Lung Cancer Collaboration Group, Youth Specialists Committee of Beijing Medical Reward Foundation.   +2 more
europepmc   +1 more source